浙江花园生物医药股份有限公司2025年半年度报告摘要

Group 1 - The company has not distributed cash dividends, issued bonus shares, or converted reserves into share capital during the reporting period [3] - There has been no change in the controlling shareholder or actual controller during the reporting period [5] - The company has no preferred shareholders or related holdings during the reporting period [5] Group 2 - All directors attended the board meeting to review the report [2] - The report does not include any non-standard audit opinions [3] - There are no significant matters reported during the period [5]